Biotech news
Biotech
When it comes to plants, European courts have been occupied with various debates over salad. Margreet van Heuvel and Bart Swinkels take a look. 16 October 2013
Biotech
The Court of Justice of the European Union’s decision in the Brüstle case has worrying implications for some stem cell patents. Andy Sanderson looks at the landscape across Europe. 16 October 2013
Americas
Dow Chemical Company subsidiary Dow AgroSciences has won another lawsuit involving its Enlist weed control technology. 10 October 2013
Biotech
With a track record of successful innovation, Munich is one of the leading lights of European biotech. LSIPR went to visit. 30 September 2013
Americas
Developing new drugs is time-consuming and expensive. DelMar Pharma researches old drugs and establishes new IP around them to streamline the process. LSIPR spoke to chief executive Jeffrey Bacha about the company’s approach. 30 September 2013
Asia
A Japanese research institution has collaborated with three Indian organisations to launch two new virtual centres for scientists and students. 25 September 2013
Asia
The Indian government has awarded more than two thirds of its recent pharmaceutical patents to foreign drug makers, according to data released by the Indian Patent Office. 16 September 2013
Asia
The Health Ministry in India has recommended that a compulsory licence is issued for the manufacture of Bristol-Myers Squibb’s anti-cancer drug Sprycel (dasatinib), potentially opening the door to the sale of cheaper imitations. 12 September 2013
Biotech
UK IP firm Marks & Clerk LLP has announced two of its attorneys will be joining the firm’s partnership. 28 August 2013
Pharma
Austria has become the first country in the EU to ratify consent to the Unified Patent Court. 27 August 2013